Agilon Health, Inc. (AGL)

AGL is positioned bullish on a range of short- and medium-term indicators while the underlying trend shows limited force. Price sits well above the 200‑day averages and multiple short/medium moving averages are signaling support, and MACD and momentum readings are both positive, indicating constructive upside bias. ADX is muted, however, suggesting the trend lacks strong directional conviction, and ATR shows above‑average volatility. On balance, volume-based OBV is supportive of the move even as the classic pivot sits near the current level. Technical takeaway: Strong Buy—short/medium momentum and moving-average support outweigh a weak ADX and elevated volatility.